Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-036044

General Counsel and Secretary sold 8,125 shares at $22.05 ($179,156)

  • General Counsel and Secretary acquired 8,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Lara General Counsel and Secretary 2022-11-15 Option exercise +8,125 $14.00 $113,750 8,125 D
Meisner Lara General Counsel and Secretary 2022-11-15 Sale −8,125 $22.05 $179,156 0 D
Derivatives
Meisner Lara General Counsel and Secretary 2022-11-15 Option exercise · Stock Option (Right to Buy) −8,125 21,875 D
Open-market sales · 8,125 sh · avg $22.05 · $179,156
Loading xslF345X03/doc4.xml…